Cover Image
Market Research Report

Global Influenza Diagnostics Market 2019-2023

Published by TechNavio (Infiniti Research Ltd.) Product code 481526
Published Content info 143 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Influenza Diagnostics Market 2019-2023
Published: July 8, 2019 Content info: 143 Pages
Description

About this market

Influenza diagnostic kits are available in both rapid and conventional testing models. These kits can detect influenza virus strains in swab samples collected from the nasal, nasopharyngeal, or oropharyngeal region. Technavio's influenza diagnostics market analysis considers sales from point-of-care testing, immunodiagnostics, and molecular diagnostics kits segments to end-user sectors such as hospitals and diagnostic laboratories, academic and research institutions, and home care. Our analysis also considers the sales of influenza diagnostics in Asia, Europe, North America, and ROW. In 2018, the point-of-care testing segment held the highest market share, which is expected to remain prevalent over the forecast period. Factors such as the rising need for rapid influenza testing in outpatient and home care settings and in physician-owned laboratories will significantly help the point-of-care testing segment in maintaining its leading market position. Also, our global Influenza diagnostics report has observed market growth factors such as the increasing demand for point-of-care diagnostics, rising focus on the prevention of pandemic influenza, and high demand for influenza diagnostics during seasonal prevalence. However, challenges such as the lack of laboratory infrastructure in developing regions, consistent development of new diagnostic procedures for emerging influenza virus, and stringent compliance and regulatory requirements may hamper the growth of the Influenza diagnostics industry over the forecast period.

Overview

Increasing demand for point-of-care diagnostics

The rising need for quick influenza monitoring and the lack of healthcare infrastructure in developing countries are increasing the need for point-of-care diagnostics, which provide rapid results. The quick antigen detection ability of rapid influenza diagnostics tests (RIDTs) help healthcare practitioners in providing timely and appropriate treatment. These factors are increasing the sales of RIDT kits, which are point-of-care products. Vendors are further focusing on improving their efficacy and precision. As a result, the market is expected to record a CAGR of almost 6% during the forecast period.

Increasing approvals of influenza diagnostic products by regulatory authorities

Key market vendors have been upgrading their products to meet compliance standards set by authorities such as the US FDA, CFDA, and ECDC. Consequently, the number of approvals is increasing. As a result, many influenza detection kits are commercially available. The sales of these kits will continue to rise owing to the growing incidence of influenza cases across the world, which will augment sales. Therefore, the increasing approvals of influenza diagnostic products by regulatory authorities will have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global influenza diagnostics market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of several major players, the global influenza diagnostics market is moderately fragmented. Technavio's robust vendor analysis is designed to help clients in improving their market position, and in line with this, this report provides a detailed analysis of several leading influenza diagnostics producers, which include Abbott Laboratories, bioMerieux SA, Bio-Rad Laboratories Inc., Danaher Corp., and Thermo Fisher Scientific Inc.

Also, the influenza diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Table of Contents
Product Code: IRTNTR31642

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: SEGMENTATION BY END-USER

PART 07: SEGMENTATION BY INDICATION

PART 08: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Point-of-care testing - Market size and forecast 2018-2023
  • Immunodiagnostics - Market size and forecast 2018-2023
  • Molecular diagnostics - Market size and forecast 2018-2023
  • Market opportunity by product

PART 09: CUSTOMER LANDSCAPE

PART 10: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Surge in number of genetic characterization studies on influenza virus
  • Increasing approvals of influenza diagnostic products by regulatory authorities
  • Rising adoption of rapid diagnostic products in physician office laboratories

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • Thermo Fisher Scientific Inc.

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

List of Exhibits

  • Exhibit 01: Years in consideration
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market characteristics analysis
  • Exhibit 06: Market segments
  • Exhibit 07: Market definition - Inclusions and exclusions checklist
  • Exhibit 08: Market size 2018
  • Exhibit 09: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 10: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 11: Five forces analysis 2018
  • Exhibit 12: Five forces analysis 2023
  • Exhibit 13: Bargaining power of buyers
  • Exhibit 14: Bargaining power of suppliers
  • Exhibit 15: Threat of new entrants
  • Exhibit 16: Threat of substitutes
  • Exhibit 17: Threat of rivalry
  • Exhibit 18: Market condition - Five forces 2018
  • Exhibit 19: Influenza A diagnostic product in commercial market space:
  • Exhibit 20: Product - Market share 2018-2023 (%)
  • Exhibit 21: Comparison by product
  • Exhibit 22: Point-of-care testing - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Point-of-care testing - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Immunodiagnostics - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 25: Immunodiagnostics - Year-over-year growth 2019-2023 (%)
  • Exhibit 26: Molecular diagnostics - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 27: Molecular diagnostics - Year-over-year growth 2019-2023 (%)
  • Exhibit 28: Market opportunity by product
  • Exhibit 29: Customer landscape
  • Exhibit 30: Customer landscape analysis
  • Exhibit 31: Market share by geography 2018-2023 (%)
  • Exhibit 32: Geographic comparison
  • Exhibit 33: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 38: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 39: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 40: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 41: Key leading countries
  • Exhibit 42: Market opportunity
  • Exhibit 43: Decision framework
  • Exhibit 44: Impact of drivers and challenges
  • Exhibit 45: Exhibit: Nucleic acid detection-based US FDA-cleared influenza diagnostics test in commercial market (as of 2019)
  • Exhibit 46: Vendor landscape
  • Exhibit 47: Landscape disruption
  • Exhibit 48: Vendor landscape analysis
  • Exhibit 49: Vendors covered
  • Exhibit 50: Vendor classification
  • Exhibit 51: Market positioning of vendors
  • Exhibit 52: Abbott Laboratories - Vendor overview
  • Exhibit 53: Abbott Laboratories - Business segments
  • Exhibit 54: Abbott Laboratories - Organizational developments
  • Exhibit 55: Abbott Laboratories - Geographic focus
  • Exhibit 56: Abbott Laboratories - Segment focus
  • Exhibit 57: Abbott Laboratories - Key offerings
  • Exhibit 58: bioMerieux SA - Vendor overview
  • Exhibit 59: bioMerieux SA - Business segments
  • Exhibit 60: bioMerieux SA - Organizational developments
  • Exhibit 61: bioMerieux SA - Geographic focus
  • Exhibit 62: bioMerieux SA - Key offerings
  • Exhibit 63: Bio-Rad Laboratories Inc. - Vendor overview
  • Exhibit 64: Bio-Rad Laboratories Inc. - Business segments
  • Exhibit 65: Bio-Rad Laboratories Inc. - Organizational developments
  • Exhibit 66: Bio-Rad Laboratories Inc. - Geographic focus
  • Exhibit 67: Bio-Rad Laboratories Inc. - Segment focus
  • Exhibit 68: Bio-Rad Laboratories Inc. - Key offerings
  • Exhibit 69: Danaher Corp. - Vendor overview
  • Exhibit 70: Danaher Corp. - Business segments
  • Exhibit 71: Danaher Corp. - Organizational developments
  • Exhibit 72: Danaher Corp. - Geographic focus
  • Exhibit 73: Danaher Corp. - Segment focus
  • Exhibit 74: Danaher Corp. - Key offerings
  • Exhibit 75: Thermo Fisher Scientific Inc. - Vendor overview
  • Exhibit 76: Thermo Fisher Scientific Inc. - Business segments
  • Exhibit 77: Thermo Fisher Scientific Inc. - Organizational developments
  • Exhibit 78: Thermo Fisher Scientific Inc. - Geographic focus
  • Exhibit 79: Thermo Fisher Scientific Inc. - Segment focus
  • Exhibit 80: Thermo Fisher Scientific Inc. - Key offerings
  • Exhibit 81: Validation techniques employed for market sizing
  • Exhibit 82: List of abbreviations
  • Exhibit 83: Definition of market positioning of vendors
Back to Top